Cargando…
Hinokitiol impedes tumor drug resistance by suppressing protein kinase B/mammalian targets of rapamycin axis
Chemotherapy is a treatment method commonly used for cancer and that patients showing low to no response to the treatment often developed drug resistance via multiple mechanisms. Natural products have been shown to reduce tumor drug resistance. Hinokitiol, a natural tropolone derivative, has potenti...
Autores principales: | Ni, Ying-Jui, Huang, Zi-Ni, Li, Hsin-Yu, Lee, Chiao-Ching, Tyan, Yu-Chang, Yang, Ming-Hui, Pangilinan, Christian R., Wu, Li-Hsien, Chiang, Yu-Chung, Lee, Che-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990411/ https://www.ncbi.nlm.nih.gov/pubmed/35399709 http://dx.doi.org/10.7150/jca.69449 |
Ejemplares similares
-
Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway
por: Wu, Yueh-Jung, et al.
Publicado: (2020) -
Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells
por: Tsao, Yu-Tzu, et al.
Publicado: (2016) -
Hinokitiol Selectively Enhances the Antibacterial Activity of Tetracyclines against Staphylococcus aureus
por: Le, Chun-Yan, et al.
Publicado: (2023) -
Hinokitiol-Loaded Mesoporous Calcium Silicate Nanoparticles Induce Apoptotic Cell Death through Regulation of the Function of MDR1 in Lung Adenocarcinoma Cells
por: Shen, Yu-Fang, et al.
Publicado: (2016) -
Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells
por: Chen, Shih-Ming, et al.
Publicado: (2017)